市場調査レポート

商品コード

1178056

抗放射線薬の世界市場：化合物別（ヨウ化カリウム、プルシアンブルー、DTPA、その他）－業界分析、市場規模、シェア、成長、動向、予測（2022年～2031年）

Anti-radiation Drugs Market (Compound: Potassium Iodide, Prussian Blue, DTPA, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

出版日: 2022年11月24日 | 発行: Transparency Market Research

| ページ情報: 英文 213 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 5,795 897,877円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Multi-user License)

USD 8,795 1,362,697円

レポートPDFを同一の部署内・課内の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Corporate License)

USD 11,795 1,827,517円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=154.94円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートでは、世界の抗放射線薬市場について調査分析し、市場概要、市場分析、競合情勢など、体系的な情報を提供しています。

市場参入企業－競合マトリックス（層および企業規模別）
市場シェア分析（2021年）：企業別
企業プロファイル
- Amgen Inc.
- Anbex Inc.
- Arco Pharmaceuticals LLC
- BTG International Inc.
- Cellphire, Inc.
- Chrysalis BioTherapeutics, Inc.
- Darnitsa
- Enzychem Lifesciences Corporation
- Humanetics Corporation
- Mission Pharmacal Company
- Myelo Therapeutics GmbH
- Partner Therapeutics
- Pluri Inc.
- その他

図表

List of Tables

Table 01: Global Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Compound, 2017-2031
Table 02: Global Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 03: Global Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 04: Global Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 05: North America Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Country, 2017-2031
Table 06: North America Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Compound, 2017-2031
Table 07: North America Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 08: North America Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 09: Europe Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 10: Europe Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Compound, 2017-2031
Table 11: Europe Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 12: Europe Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 13: Asia Pacific Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Asia Pacific Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Compound, 2017-2031
Table 15: Asia Pacific Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 16: Asia Pacific Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 17: Latin America Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Compound, 2017-2031
Table 19: Latin America Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 20: Latin America Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 21: Middle East & Africa Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Middle East & Africa Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Compound, 2017-2031
Table 23: Middle East & Africa Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 24: Middle East & Africa Anti-radiation Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

Figure 01: Global Anti-radiation Drugs Market Size (US$ Mn) and Distribution (%), by Region, 2017 and 2031
Figure 02: Global Anti-radiation Drugs Market Revenue (US$ Mn), by Compound, 2021
Figure 03: Global Anti-radiation Drugs Market Value Share, by Compound, 2021
Figure 04: Global Anti-radiation Drugs Market Revenue (US$ Mn), by Application, 2021
Figure 05: Global Anti-radiation Drugs Market Value Share, by Application, 2021
Figure 06: Global Anti-radiation Drugs Market Revenue (US$ Mn), by Distribution Channel, 2021
Figure 07: Global Anti-radiation Drugs Market Value Share, by Distribution Channel, 2021
Figure 08: Global Anti-radiation Drugs Market Value Share, by Region, 2021
Figure 09: Global Anti-radiation Drugs Market Value (US$ Mn) Forecast, 2017-2031
Figure 10: Global Anti-radiation Drugs Market Value Share Analysis, by Compound, 2017 and 2031
Figure 11: Global Anti-radiation Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Potassium Iodide (KI), 2017-2031
Figure 12: Global Anti-radiation Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DTPA (Diethylenetriamine Pentaacetate), 2017-2031
Figure 13: Global Anti-radiation Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prussian Blue, 2017-2031
Figure 14: Global Anti-radiation Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
Figure 15: Global Anti-radiation Drugs Market Attractiveness Analysis, by Compound, 2022-2031
Figure 16: Global Anti-radiation Drugs Market Value Share Analysis, by Application, 2017 and 2031
Figure 17: Global Anti-radiation Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Acute Radiation Syndrome (ARS), 2017-2031
Figure 18: Global Anti-radiation Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer Treatment, 2017-2031
Figure 19: Global Anti-radiation Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Radiation Exposure, 2017-2031
Figure 20: Global Anti-radiation Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
Figure 21: Global Anti-radiation Drugs Market Attractiveness Analysis, by Application, 2022-2031
Figure 22: Global Anti-radiation Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2031
Figure 23: Global Anti-radiation Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017-2031
Figure 24: Global Anti-radiation Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017-2031
Figure 25: Global Anti-radiation Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
Figure 26: Global Anti-radiation Drugs Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 27: Global Anti-radiation Drugs Market Value Share Analysis, by Region, 2017 and 2031
Figure 28: Global Anti-radiation Drugs Market Attractiveness Analysis, by Region, 2022-2031
Figure 29: North America Anti-radiation Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 30: North America Anti-radiation Drugs Market Attractiveness Analysis, by Country, 2017-2031
Figure 31: North America Anti-radiation Drugs Market Value Share Analysis, by Country, 2017 and 2031
Figure 32: North America Anti-radiation Drugs Market Value Share Analysis, by Compound, 2017 and 2031
Figure 33: North America Anti-radiation Drugs Market Value Share Analysis, by Application, 2017 and 2031
Figure 34: North America Anti-radiation Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2031
Figure 35: North America Anti-radiation Drugs Market Attractiveness Analysis, by Compound, 2022-2031
Figure 36: North America Anti-radiation Drugs Market Attractiveness Analysis, by Application, 2022-2031
Figure 37:North America Anti-radiation Drugs Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 38: Europe Anti-radiation Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 39: Europe Anti-radiation Drugs Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
Figure 40: Europe Anti-radiation Drugs Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 41: Europe Anti-radiation Drugs Market Value Share Analysis, by Compound, 2017 and 2031
Figure 42: Europe Anti-radiation Drugs Market Value Share Analysis, by Application, 2017 and 2031
Figure 43: Europe Anti-radiation Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2031
Figure 44: Europe Anti-radiation Drugs Market Attractiveness Analysis, by Compound, 2022-2031
Figure 45: Europe Anti-radiation Drugs Market Attractiveness Analysis, by Application, 2022-2031
Figure 46: Europe Anti-radiation Drugs Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 47: Asia Pacific Anti-radiation Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 48: Asia Pacific Anti-radiation Drugs Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
Figure 49: Asia Pacific Anti-radiation Drugs Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 50: Asia Pacific Anti-radiation Drugs Market Value Share Analysis, by Compound, 2017 and 2031
Figure 51: Asia Pacific Anti-radiation Drugs Market Value Share Analysis, by Application, 2017 and 2031
Figure 52: Asia Pacific Anti-radiation Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2031
Figure 53: Asia Pacific Anti-radiation Drugs Market Attractiveness Analysis, by Compound, 2022-2031
Figure 54: Asia Pacific Anti-radiation Drugs Market Attractiveness Analysis, by Application, 2022-2031
Figure 55: Asia Pacific Anti-radiation Drugs Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 56: Latin America Anti-radiation Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 57: Latin America Anti-radiation Drugs Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
Figure 58: Latin America Anti-radiation Drugs Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 59: Latin America Anti-radiation Drugs Market Value Share Analysis, by Compound, 2017 and 2031
Figure 60: Latin America Anti-radiation Drugs Market Value Share Analysis, by Application, 2017 and 2031
Figure 61: Latin America Anti-radiation Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2031
Figure 62: Latin America Anti-radiation Drugs Market Attractiveness Analysis, by Compound, 2022-2031
Figure 63: Latin America Anti-radiation Drugs Market Attractiveness Analysis, by Application, 2022-2031
Figure 64: Latin America Anti-radiation Drugs Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 65: Middle East & Africa Anti-radiation Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 66: Middle East & Africa Anti-radiation Drugs Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
Figure 67: Middle East & Africa Anti-radiation Drugs Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 68: Middle East & Africa Anti-radiation Drugs Market Value Share Analysis, by Compound, 2017 and 2031
Figure 69: Middle East & Africa Anti-radiation Drugs Market Value Share Analysis, by Application, 2017 and 2031
Figure 70: Middle East & Africa Anti-radiation Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2031
Figure 71: Middle East & Africa Anti-radiation Drugs Market Attractiveness Analysis, by Compound, 2022-2031
Figure 72: Middle East & Africa Anti-radiation Drugs Market Attractiveness Analysis, by Application, 2022-2031
Figure 73: Middle East & Africa Anti-radiation Drugs Market Attractiveness Analysis, by Distribution Channel, 2022-2031

Product Code: TMRGL85240

TMR's report on the global anti-radiation drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global anti-radiation drugs market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global anti-radiation drugs market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the anti-radiation drugs market.

The report delves into the competitive landscape of the global anti-radiation drugs market. Key players operating in the global anti-radiation drugs market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global anti-radiation drugs market profiled in this report.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Anti-radiation Drugs Market

4. Market Overview

4.1. Introduction
- 4.1.1. Definition
- 4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Anti-radiation Drugs Market Analysis and Forecast, 2017-2031

5. Key Insights

5.1. Pipeline Analysis
5.2. Key Industry Events (Partnership, Investment, Merger & Acquisition, etc.)
5.3. Insights on Radiation Pills
5.4. Regulatory Scenario, by Key Region/ Country
5.5. COVID-19 Impact Analysis

6. Global Anti-radiation Drugs Market Analysis and Forecast, by Compound

6.1. Introduction & Definition
6.2. Market Value Forecast, by Compound, 2017-2031
- 6.2.1. Potassium Iodide (KI)
- 6.2.2. Prussian Blue
- 6.2.3. DTPA (Diethylenetriamine Pentaacetate)
- 6.2.4. Others
6.3. Market Attractiveness, by Compound

7. Global Anti-radiation Drugs Market Analysis and Forecast, by Application

7.1. Introduction & Definition
7.2. Market Value Forecast, by Application, 2017-2031
- 7.2.1. Acute Radiation Syndrome (ARS)
- 7.2.2. Cancer Treatment
- 7.2.3. Radiation Exposure
- 7.2.4. Others
7.3. Market Attractiveness Analysis, by Application

8. Global Anti-radiation Drugs Market Analysis and Forecast, by Distribution Channel

8.1. Introduction & Definition
8.2. Market Value Forecast, by Distribution Channel, 2017-2031
- 8.2.1. Hospital Pharmacies
- 8.2.2. Retail Pharmacies
- 8.2.3. Others
8.3. Market Attractiveness Analysis, by Distribution Channel

9. Global Anti-radiation Drugs Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Anti-radiation Drugs Market Analysis and Forecast

10.1. Introduction
- 10.1.1. Key Findings
10.2. Market Value Forecast, by Compound, 2017-2031
- 10.2.1. Potassium Iodide (KI)
- 10.2.2. Prussian Blue
- 10.2.3. DTPA (Diethylenetriamine Pentaacetate)
- 10.2.4. Others
10.3. Market Value Forecast, by Application, 2017-2031
- 10.3.1. Acute Radiation Syndrome (ARS)
- 10.3.2. Cancer Treatment
- 10.3.3. Radiation Exposure
- 10.3.4. Others
10.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 10.4.1. Hospital Pharmacies
- 10.4.2. Retail Pharmacies
- 10.4.3. Others
10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
10.6. Market Attractiveness Analysis
- 10.6.1. By Compound
- 10.6.2. By Application
- 10.6.3. By Distribution Channel
- 10.6.4. By Country

11. Europe Anti-radiation Drugs Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Compound, 2017-2031
- 11.2.1. Potassium Iodide (KI)
- 11.2.2. Prussian Blue
- 11.2.3. DTPA (Diethylenetriamine Pentaacetate)
- 11.2.4. Others
11.3. Market Value Forecast, by Application, 2017-2031
- 11.3.1. Acute Radiation Syndrome (ARS)
- 11.3.2. Cancer Treatment
- 11.3.3. Radiation Exposure
- 11.3.4. Others
11.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 11.4.1. Hospital Pharmacies
- 11.4.2. Retail Pharmacies
- 11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
- 11.6.1. By Compound
- 11.6.2. By Application
- 11.6.3. By Distribution Channel
- 11.6.4. By Country/Sub-region

12. Asia Pacific Anti-radiation Drugs Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Compound, 2017-2031
- 12.2.1. Potassium Iodide (KI)
- 12.2.2. Prussian Blue
- 12.2.3. DTPA (Diethylenetriamine Pentaacetate)
- 12.2.4. Others
12.3. Market Value Forecast, by Application, 2017-2031
- 12.3.1. Acute Radiation Syndrome (ARS)
- 12.3.2. Cancer Treatment
- 12.3.3. Radiation Exposure
- 12.3.4. Others
12.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 12.4.1. Hospital Pharmacies
- 12.4.2. Retail Pharmacies
- 12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
- 12.6.1. By Compound
- 12.6.2. By Application
- 12.6.3. By Distribution Channel
- 12.6.4. By Country/Sub-region

13. Latin America Anti-radiation Drugs Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Compound, 2017-2031
- 13.2.1. Potassium Iodide (KI)
- 13.2.2. Prussian Blue
- 13.2.3. DTPA (Diethylenetriamine Pentaacetate)
- 13.2.4. Others
13.3. Market Value Forecast, by Application, 2017-2031
- 13.3.1. Acute Radiation Syndrome (ARS)
- 13.3.2. Cancer Treatment
- 13.3.3. Radiation Exposure
- 13.3.4. Others
13.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 13.4.1. Hospital Pharmacies
- 13.4.2. Retail Pharmacies
- 13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
- 13.6.1. By Compound
- 13.6.2. By Application
- 13.6.3. By Distribution Channel
- 13.6.4. By Country/Sub-region

14. Middle East & Africa Anti-radiation Drugs Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Compound, 2017-2031
- 14.2.1. Potassium Iodide (KI)
- 14.2.2. Prussian Blue
- 14.2.3. DTPA (Diethylenetriamine Pentaacetate)
- 14.2.4. Others
14.3. Market Value Forecast, by Application, 2017-2031
- 14.3.1. Acute Radiation Syndrome (ARS)
- 14.3.2. Cancer Treatment
- 14.3.3. Radiation Exposure
- 14.3.4. Others
14.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 14.4.1. Hospital Pharmacies
- 14.4.2. Retail Pharmacies
- 14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
- 14.6.1. By Compound
- 14.6.2. By Application
- 14.6.3. By Distribution Channel
- 14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player - Competitive Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2021)
15.3. Company Profiles
- 15.3.1. Amgen Inc.
  - 15.3.1.1. Company Overview
  - 15.3.1.2. Compound Portfolio
  - 15.3.1.3. SWOT Analysis
  - 15.3.1.4. Financial Overview
  - 15.3.1.5. Strategic Overview
- 15.3.2. Anbex Inc.
  - 15.3.2.1. Company Overview
  - 15.3.2.2. Compound Portfolio
  - 15.3.2.3. SWOT Analysis
  - 15.3.2.4. Financial Overview
  - 15.3.2.5. Strategic Overview
- 15.3.3. Arco Pharmaceuticals LLC
  - 15.3.3.1. Company Overview
  - 15.3.3.2. Compound Portfolio
  - 15.3.3.3. SWOT Analysis
  - 15.3.3.4. Financial Overview
- 15.3.4. BTG International Inc.
  - 15.3.4.1. Company Overview
  - 15.3.4.2. Compound Portfolio
  - 15.3.4.3. SWOT Analysis
  - 15.3.4.4. Financial Overview
  - 15.3.4.5. Strategic Overview
- 15.3.5. Cellphire, Inc.
  - 15.3.5.1. Company Overview
  - 15.3.5.2. Compound Portfolio
  - 15.3.5.3. SWOT Analysis
  - 15.3.5.4. Financial Overview
  - 15.3.5.5. Strategic Overview
- 15.3.6. Chrysalis BioTherapeutics, Inc.
  - 15.3.6.1. Company Overview
  - 15.3.6.2. Compound Portfolio
  - 15.3.6.3. SWOT Analysis
- 15.3.7. Darnitsa
  - 15.3.7.1. Company Overview
  - 15.3.7.2. Compound Portfolio
  - 15.3.7.3. SWOT Analysis
  - 15.3.7.4. Strategic Overview
- 15.3.8. Enzychem Lifesciences Corporation
  - 15.3.8.1. Company Overview
  - 15.3.8.2. Compound Portfolio
  - 15.3.8.3. SWOT Analysis
  - 15.3.8.4. Strategic Overview
- 15.3.9. Humanetics Corporation
  - 15.3.9.1. Company Overview
  - 15.3.9.2. Compound Portfolio
  - 15.3.9.3. SWOT Analysis
  - 15.3.9.4. Financial Overview
  - 15.3.9.5. Strategic Overview
- 15.3.10. Mission Pharmacal Company
  - 15.3.10.1. Company Overview
  - 15.3.10.2. Compound Portfolio
  - 15.3.10.3. SWOT Analysis
  - 15.3.10.4. Financial Overview
  - 15.3.10.5. Strategic Overview
- 15.3.11. Myelo Therapeutics GmbH
  - 15.3.11.1. Company Overview
  - 15.3.11.2. Compound Portfolio
  - 15.3.11.3. SWOT Analysis
  - 15.3.11.4. Financial Overview
  - 15.3.11.5. Strategic Overview
- 15.3.12. Partner Therapeutics
  - 15.3.12.1. Company Overview
  - 15.3.12.2. Compound Portfolio
  - 15.3.12.3. SWOT Analysis
  - 15.3.12.4. Financial Overview
  - 15.3.12.5. Strategic Overview
- 15.3.13. Pluri Inc.
  - 15.3.13.1. Company Overview
  - 15.3.13.2. Compound Portfolio
  - 15.3.13.3. SWOT Analysis
  - 15.3.13.4. Financial Overview
  - 15.3.13.5. Strategic Overview
- 15.3.14. Other Players
  - 15.3.14.1. Company Overview
  - 15.3.14.2. Compound Portfolio
  - 15.3.14.3. SWOT Analysis
  - 15.3.14.4. Financial Overview
  - 15.3.14.5. Strategic Overview

抗放射線薬の世界市場：化合物別（ヨウ化カリウム、プルシアンブルー、DTPA、その他）－業界分析、市場規模、シェア、成長、動向、予測（2022年～2031年）

Anti-radiation Drugs Market (Compound: Potassium Iodide, Prussian Blue, DTPA, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

目次

第1章序文

第2章前提と調査手法

第3章エグゼクティブサマリー：世界の抗放射線薬市場

第4章市場概要

第5章主な洞察

第6章世界の抗放射線薬市場の分析と予測：化合物別

第7章世界の抗放射線薬市場の分析と予測：用途別

第8章世界の抗放射線薬市場の分析と予測：流通チャネル別

第9章世界の抗放射線薬市場の分析と予測：地域別

第10章北米の抗放射線薬市場の分析と予測

第11章欧州の抗放射線薬市場の分析と予測

第12章アジア太平洋の抗放射線薬市場の分析と予測

第13章ラテンアメリカの抗放射線薬市場の分析と予測

第14章中東およびアフリカの抗放射線薬市場の分析と予測

第15章競合情勢

List of Tables

List of Figures

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Anti-radiation Drugs Market

4. Market Overview

5. Key Insights

6. Global Anti-radiation Drugs Market Analysis and Forecast, by Compound

7. Global Anti-radiation Drugs Market Analysis and Forecast, by Application

8. Global Anti-radiation Drugs Market Analysis and Forecast, by Distribution Channel

9. Global Anti-radiation Drugs Market Analysis and Forecast, by Region

10. North America Anti-radiation Drugs Market Analysis and Forecast

11. Europe Anti-radiation Drugs Market Analysis and Forecast

12. Asia Pacific Anti-radiation Drugs Market Analysis and Forecast

13. Latin America Anti-radiation Drugs Market Analysis and Forecast

14. Middle East & Africa Anti-radiation Drugs Market Analysis and Forecast

15. Competition Landscape

抗放射線薬の世界市場：化合物別（ヨウ化カリウム、プルシアンブルー、DTPA、その他）－業界分析、市場規模、シェア、成長、動向、予測（2022年～2031年）

Anti-radiation Drugs Market (Compound: Potassium Iodide, Prussian Blue, DTPA, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

目次

第1章 序文

第2章 前提と調査手法

第3章 エグゼクティブサマリー：世界の抗放射線薬市場

第4章 市場概要

第5章 主な洞察

第6章 世界の抗放射線薬市場の分析と予測：化合物別

第7章 世界の抗放射線薬市場の分析と予測：用途別

第8章 世界の抗放射線薬市場の分析と予測：流通チャネル別

第9章 世界の抗放射線薬市場の分析と予測：地域別

第10章 北米の抗放射線薬市場の分析と予測

第11章 欧州の抗放射線薬市場の分析と予測

第12章 アジア太平洋の抗放射線薬市場の分析と予測

第13章 ラテンアメリカの抗放射線薬市場の分析と予測

第14章 中東およびアフリカの抗放射線薬市場の分析と予測

第15章 競合情勢

List of Tables

List of Figures

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Anti-radiation Drugs Market

4. Market Overview

5. Key Insights

6. Global Anti-radiation Drugs Market Analysis and Forecast, by Compound

7. Global Anti-radiation Drugs Market Analysis and Forecast, by Application

8. Global Anti-radiation Drugs Market Analysis and Forecast, by Distribution Channel

9. Global Anti-radiation Drugs Market Analysis and Forecast, by Region

10. North America Anti-radiation Drugs Market Analysis and Forecast

11. Europe Anti-radiation Drugs Market Analysis and Forecast

12. Asia Pacific Anti-radiation Drugs Market Analysis and Forecast

13. Latin America Anti-radiation Drugs Market Analysis and Forecast

14. Middle East & Africa Anti-radiation Drugs Market Analysis and Forecast

15. Competition Landscape

第1章序文

第2章前提と調査手法

第3章エグゼクティブサマリー：世界の抗放射線薬市場

第4章市場概要

第5章主な洞察

第6章世界の抗放射線薬市場の分析と予測：化合物別

第7章世界の抗放射線薬市場の分析と予測：用途別

第8章世界の抗放射線薬市場の分析と予測：流通チャネル別

第9章世界の抗放射線薬市場の分析と予測：地域別

第10章北米の抗放射線薬市場の分析と予測

第11章欧州の抗放射線薬市場の分析と予測

第12章アジア太平洋の抗放射線薬市場の分析と予測

第13章ラテンアメリカの抗放射線薬市場の分析と予測

第14章中東およびアフリカの抗放射線薬市場の分析と予測

第15章競合情勢